AADA 📈 21Shares Cardano ETP CHF - Overview

Exchange: SW • Country: Switzerland • Currency: USD • Type: Etf • ISIN: CH1102728750 • Digital Assets

AADA: Bitcoin, Ethereum, Cardano

‣ Company URL: https://amun.com ‣ Domicile: Switzerland

Additional Sources for AADA ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

AADA ETF Overview

Market Cap in USD 89m
Category Digital Assets
TER 2.50%
IPO / Inception 2021-04-26

AADA ETF Ratings

Growth 5y -42.2%
Fundamental -
Dividend -
Rel. Strength Industry 1388
Analysts -
Fair Price Momentum 15.20 USD
Fair Price DCF -

AADA Dividends

No Dividends Paid

AADA Growth Ratios

Growth Correlation 3m 82.3%
Growth Correlation 12m -15.3%
Growth Correlation 5y -56.8%
CAGR 5y -11.96%
CAGR/Mean DD 5y -0.16
Sharpe Ratio 12m 1.08
Alpha 64.19
Beta 1.12
Volatility 191.51%
Current Volume 0k
Average Volume 20d 1.6k
What is the price of AADA stocks?
As of January 14, 2025, the stock is trading at USD 15.65 with a total of 0 shares traded.
Over the past week, the price has changed by -17.13%, over one month by -15.94%, over three months by +169.85% and over the past year by +76.11%.
Is 21Shares Cardano ETP CHF a good stock to buy?
Probably not. Based on ValueRay Analyses, 21Shares Cardano ETP CHF (SW:AADA) is currently (January 2025) not a good stock to buy. It has a ValueRay Growth Rating of -42.18 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AADA as of January 2025 is 15.20. This means that AADA is currently overvalued and has a potential downside of -2.88%.
Is AADA a buy, sell or hold?
21Shares Cardano ETP CHF has no consensus analysts rating.
What are the forecast for AADA stock price target?
According to ValueRays Forecast Model, AADA 21Shares Cardano ETP CHF will be worth about 17 in January 2026. The stock is currently trading at 15.65. This means that the stock has a potential upside of +8.43%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 17 8.4%